News

MCTD May Be Subset of Systemic Scleroderma


 

EXPERT ANALYSIS FROM THE CONGRESS OF CLINICAL RHEUMATOLOGY

Also, as in scleroderma, the pulmonary vessels – even in patients who didn’t have pulmonary hypertension – had similar but less extensive disease, she added.

Based on these various findings, which together show a great deal of similarity to scleroderma while highlighting numerous differences from other connective tissue diseases, Dr. Steen said she is increasingly convinced that MCTD is not a unique entity, mixed disease, or subset of lupus, but is actually a subset of systemic scleroderma.

Dr. Steen reported having no disclosures relevant to her presentation.

Pages

Recommended Reading

Avoid Certain Vaccine-Biologic Combos
MDedge Rheumatology
Smokers Less Likely to Respond to Biologic Treatment for RA
MDedge Rheumatology
Could a Urine Test Predict Response to Biologics?
MDedge Rheumatology
ACR Releases Updated Lupus Nephritis Guidelines
MDedge Rheumatology
ACR Gives Special Consideration to Pregnancy in Nephritis Guidelines
MDedge Rheumatology
Scleroderma Malignancy Risk Linked to Antinuclear Antibodies
MDedge Rheumatology
Digital Ulcer Disease in Systemic Sclerosis
MDedge Rheumatology
Psoriasis Boosts Crohn's Risk Fourfold
MDedge Rheumatology
High-Dose Ustekinumab Stomps Out Palmoplantar Psoriasis
MDedge Rheumatology
Physical Therapy Only Option for Skin Thickening in Scleroderma
MDedge Rheumatology